尿酸与淋巴细胞计数联合作用对老年风湿性心脏病瓣膜置换术后不良结局的影响
本研究在949例接受瓣膜置换术的老年风湿性心脏病患者中,探讨尿酸/淋巴细胞比值(ULAR)与不良事件的关联。ULAR对院内死亡的预测价值(AUC 0.703)高于单独尿酸或淋巴细胞计数,最佳截断值为3.7,且是院内和1年死亡的独立预测因子。ULAR可作为术前风险分层方法。
要点
- ULAR对院内死亡预测AUC为0.703,优于单独尿酸或淋巴细胞计数。
- ULAR是院内死亡(aOR 1.17)和1年死亡(aHR 1.13)的独立预测因子。
- ULAR>3.7者院内和1年累积死亡风险显著更高。
核心结论
- ULAR联合尿酸与淋巴细胞计数,对老年风湿性心脏病瓣膜置换术患者具有更优的预后价值,可作为术前风险分层方法。
研究设计与样本
- 单中心回顾性队列分析,纳入949例接受瓣膜置换术的老年风湿性心脏病患者,采用单因素和多因素分析。
主要发现
- ULAR对院内死亡的AUC为0.703(95%CI 0.630-0.776,P<.001),最佳截断值3.7(灵敏度82.1%,特异度52.4%)。
- ULAR是院内死亡(调整OR 1.17,95%CI 1.07-1.29,P=.001)和1年死亡(调整HR 1.13,95%CI 1.03-1.25,P=.010)的独立预测因子。
- 院内死亡率从ULAR最低三分位至最高三分位递增(P<.001),且ULAR>3.7者显著更高(P<.001)。
- 1年累积术后死亡风险在ULAR>3.7者(P<.001)或ULAR最高三分位者(P<.001)显著更高。
关键数值与推荐
- ULAR计算方式为血清尿酸(mg/dL)除以淋巴细胞计数(×10^9/L)。
- ULAR按三分位分为3组,并根据ROC曲线选取截断值3.7。
临床怎么用
- 术前可计算ULAR,以3.7为截断值识别高危患者,辅助风险分层和围术期管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Increased uric acid and decreased lymphocyte count are common in elderly patients or those with heart failure, which were prognostic markers. We aimed to investigate the joint effect of uric acid and lymphocyte count for risk stratification in elderly patients with rheumatic heart disease undergoing valve replacement surgery. METHODS: Uric acid to lymphocyte ratio was calculated as serum uric acid (mg/dL)/lymphocyte count (×109/L). Univariate and multivariate analyses were performed to investigate the association of uric acid to lymphocyte ratio, with adverse events in 949 elderly patients with rheumatic heart disease undergoing valve replacement surgery. For clinical use, the uric acid to lymphocyte ratio was classified into 3 groups by the tertile, and a cutoff was also selected according to the receiver operator characteristic curve. RESULTS: Uric acid to lymphocyte ratio produced relatively higher predictive value (area under the curve, 0.703; 95% confidence interval [CI], 0.630-0.776; P < .001) than uric acid or lymphocyte count for in-hospital mortality, and the optimal cutoff was 3.7 (sensitivity, 82.1%; specificity, 52.4%). Uric acid to lymphocyte ratio was an independent predictor for in-hospital (adjusted odds ratio, 1.17; 95% CI, 1.07-1.29; P = .001) and 1-year mortality (adjusted hazard ratio, 1.13; 95% CI, 1.03-1.25; P = .010). The in-hospital mortality increased from the lowest to the highest uric acid to lymphocyte ratio tertile (P < .001) and significantly higher in patients with uric acid to lymphocyte ratio greater than 3.7 (P < .001). The cumulative 1-year postoperative mortality risk was significantly higher in patients with uric acid to lymphocyte ratio greater than 3.7 (P < .001) or upper uric acid to lymphocyte ratio tertile (P < .001). CONCLUSIONS: Uric acid to lymphocyte ratio, combining the effect of uric acid and lymphocyte count, produced more prognostic value in elderly patients with rheumatic heart disease undergoing valve replacement surgery, which could be considered as a preoperative risk-stratified method.
引用
- Wei XB, Chen WJ, Duan CY, et al. Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2018. PMID: 30459109. doi:10.1016/j.jtcvs.2018.10.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。